Releases
-
91ĚƲ®»˘ investigators have devised a system to alert health IT teams to deteriorating performance in clinical prediction models.
Dec 10, 2020
-
The isolation of human monoclonal antibodies against dangerous viruses including EEEV, Hendra and Nipah could offer new ways to treat and prevent these infections.
Dec 10, 2020
-
COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients.
Dec 10, 2020
-
91ĚƲ®»˘ University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis.
Dec 10, 2020
-
Discovery provides insight for developing next generation optoelectronic and infrared devices In groundbreaking new research, an international team that includes a 91ĚƲ®»˘ engineer has developed a unique process for producing a quantum state that is part light and part matter.
Dec 7, 2020
-
James Crowe Jr., MD, a physician-scientist at 91ĚƲ®»˘ University Medical Center who has pioneered development of human monoclonal antibodies as potential treatments for viral diseases, has won a 2020 “Golden Goose” Award.
Dec 1, 2020
-
91ĚƲ®»˘ University Medical Center (VUMC) researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease.
Nov 17, 2020
-
A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs.
Nov 17, 2020
-
Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19.
Nov 16, 2020
-
Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression.
Nov 16, 2020
-
Consuelo Wilkins’ transformative public health engagement methods recognized with National Academy of Medicine election
Consuelo Hopkins Wilkins, professor of medicine in the School of Medicine and vice president for health equity at 91ĚƲ®»˘ University Medical Center, has received one of the highest honors in health and medicine. Read MoreNov 13, 2020
-
91ĚƲ®»˘ researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer.
Nov 12, 2020
-
A new study from 91ĚƲ®»˘ epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women.
Nov 12, 2020
-
A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions.
Nov 10, 2020
-
Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.
Nov 9, 2020
-
New research documents how COVID-19 multiplies stress and trauma for people with disabilities
A November article published in Rehabilitation Psychology reviews research on disabilities and COVID-19 to help rehabilitation psychologists mitigate the effects of the added stress of the pandemic. In addition, the work addresses how systemic discrimination against people with disabilities intersects with other forms of inequity. Read MoreNov 4, 2020
-
Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.
Nov 3, 2020
-
91ĚƲ®»˘ University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.
Nov 2, 2020
-
Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize
Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research. Read MoreNov 2, 2020
-
Peptides derived from the antimicrobial peptides secreted by frogs could function as microbicides to limit HIV transmission, while sparing protective vaginal bacteria.
Nov 2, 2020